Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:PLCSD
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio:
- P/E Growth:
Frequently Asked Questions for Viveve Medical (OTCMKTS:PLCSD)
What is Viveve Medical's stock symbol?
Viveve Medical trades on the OTCMKTS under the ticker symbol "PLCSD."
Where is Viveve Medical's stock going? Where will Viveve Medical's stock price be in 2017?
1 analysts have issued 1-year price objectives for Viveve Medical's shares. Their forecasts range from $11.00 to $11.00. On average, they expect Viveve Medical's share price to reach $11.00 in the next year. View Analyst Ratings for Viveve Medical.
Who are some of Viveve Medical's key competitors?
Some companies that are related to Viveve Medical include Lundin Petroleum A Spon (LNDNY), Banco Popolare (BPSAY), DAILY MAIL&GEN TST SPON (DMTGY), African Barrick Gold Ltd (ABGLY), Solvay S.A. (SVYZY), Tencent Holdings Ltd (TCEHY), Nestle SA (NSRGY), Cable & Wireless Communications Plc (CWIXF), L'Oreal SA (LRLCY), Naspers Limited (NPSNY), Allianz SE (AZSEY), Basf Se (BASFY), Softbank Corp. (Japan) (SFTBY), Volkswagen AG (VLKAY), Reckitt Benckiser Group Plc-ADR (RBGLY), Australia and New Zealand Banking (ANZBY), National Australia Bank (NABZY) and Glencore International PLC, St. Helier (GLCNF).
How do I buy Viveve Medical stock?
Shares of Viveve Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Viveve Medical stock cost?
One share of Viveve Medical stock can currently be purchased for approximately $0.81.
Consensus Ratings for Viveve Medical (OTCMKTS:PLCSD) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$11.00|
Analysts' Ratings History for Viveve Medical (OTCMKTS:PLCSD)
(Data available from 5/24/2015 forward)
|6/21/2016||Maxim Group||Lower Price Target||Buy||$16.00 -> $11.00|
Earnings History for Viveve Medical (OTCMKTS:PLCSD)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Viveve Medical (OTCMKTS:PLCSD)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Viveve Medical (OTCMKTS:PLCSD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Viveve Medical (OTCMKTS:PLCSD)Insider Trades by Quarter for Viveve Medical (OTCMKTS:PLCSD)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/23/2014||5Am Partners Ii, Llc||Major Shareholder||Buy||5,215,664||$0.53||$2,764,301.92|| |
|9/23/2014||Daniel Janney||Director||Buy||1,895,788||$0.53||$1,004,767.64|| |
Headline Trends for Viveve Medical (OTCMKTS:PLCSD)
Latest Headlines for Viveve Medical (OTCMKTS:PLCSD)
No headlines for this company have been tracked by MarketBeat.com
Viveve Medical (PLCSD) Chart for Wednesday, May, 24, 2017